Cargando…
Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis
BACKGROUND: Clinical practice guidelines (CPGs) have long served as an essential tool for clinicians to rationalize their treatment in practice. However, the quality of guidelines varies greatly. The present study aimed to analyze high-quality CPGs of idiopathic pulmonary fibrosis (IPF) and highligh...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723592/ https://www.ncbi.nlm.nih.gov/pubmed/33313150 http://dx.doi.org/10.21037/atm-20-3200 |
_version_ | 1783620372644495360 |
---|---|
author | Li, Xuanlin Yu, Xueqing Xie, Yang Feng, Zhenzhen Ma, Yanfang Chen, Yaolong Li, Jiansheng |
author_facet | Li, Xuanlin Yu, Xueqing Xie, Yang Feng, Zhenzhen Ma, Yanfang Chen, Yaolong Li, Jiansheng |
author_sort | Li, Xuanlin |
collection | PubMed |
description | BACKGROUND: Clinical practice guidelines (CPGs) have long served as an essential tool for clinicians to rationalize their treatment in practice. However, the quality of guidelines varies greatly. The present study aimed to analyze high-quality CPGs of idiopathic pulmonary fibrosis (IPF) and highlight the potential for further improvement. METHODS: Three guideline developers’ websites, PubMed, Embase, and Web of Science, as well as a public search engine, Google Scholar, were searched to retrieve CPGs regarding the management of IPF. The methodology and reporting quality of retrieved CPGs were assessed using the validated Appraisal of Guidelines for Research and Evaluation Instrument II (AGREE II) and Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist. RESULTS: Twelve IPF CPGs were reviewed, among which 7 (58.3%) were considered as “recommended” and 1 (8.3%) as “recommended with modifications”. Among the 6 domains of AGREE II, scope and purpose (70.99%) and clarity of presentation (68.06%) were considered to be the fields in which CPGs performed best, evidenced by the highest mean AGREE II scores. The domains in which the reviewed CPGs received the lowest mean scores were rigor of development (50.87%) and applicability (34.14%). The intraclass correlation coefficient scores were excellent in each domain. The basic information domain received the highest overall reporting rate in the 7 domains of the RIGHT checklist; the other 6 domains had a full reporting rate of <50%. Eight items had a satisfactory level of reporting, whereas 14 items had poor reporting according to the RIGHT checklist. Correlation analysis revealed a highly positive correlation between the methodology and reporting quality of CPGs for IPF (r=0.872). CONCLUSIONS: The methodological quality of selected IPF CPGs fluctuated greatly, and the full reporting rate was found to be quite low in some domains. In the future, we should focus not only on improving the methodological quality in the development of guidelines, but also on the reporting quality of guidelines. |
format | Online Article Text |
id | pubmed-7723592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-77235922020-12-10 Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis Li, Xuanlin Yu, Xueqing Xie, Yang Feng, Zhenzhen Ma, Yanfang Chen, Yaolong Li, Jiansheng Ann Transl Med Original Article BACKGROUND: Clinical practice guidelines (CPGs) have long served as an essential tool for clinicians to rationalize their treatment in practice. However, the quality of guidelines varies greatly. The present study aimed to analyze high-quality CPGs of idiopathic pulmonary fibrosis (IPF) and highlight the potential for further improvement. METHODS: Three guideline developers’ websites, PubMed, Embase, and Web of Science, as well as a public search engine, Google Scholar, were searched to retrieve CPGs regarding the management of IPF. The methodology and reporting quality of retrieved CPGs were assessed using the validated Appraisal of Guidelines for Research and Evaluation Instrument II (AGREE II) and Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist. RESULTS: Twelve IPF CPGs were reviewed, among which 7 (58.3%) were considered as “recommended” and 1 (8.3%) as “recommended with modifications”. Among the 6 domains of AGREE II, scope and purpose (70.99%) and clarity of presentation (68.06%) were considered to be the fields in which CPGs performed best, evidenced by the highest mean AGREE II scores. The domains in which the reviewed CPGs received the lowest mean scores were rigor of development (50.87%) and applicability (34.14%). The intraclass correlation coefficient scores were excellent in each domain. The basic information domain received the highest overall reporting rate in the 7 domains of the RIGHT checklist; the other 6 domains had a full reporting rate of <50%. Eight items had a satisfactory level of reporting, whereas 14 items had poor reporting according to the RIGHT checklist. Correlation analysis revealed a highly positive correlation between the methodology and reporting quality of CPGs for IPF (r=0.872). CONCLUSIONS: The methodological quality of selected IPF CPGs fluctuated greatly, and the full reporting rate was found to be quite low in some domains. In the future, we should focus not only on improving the methodological quality in the development of guidelines, but also on the reporting quality of guidelines. AME Publishing Company 2020-11 /pmc/articles/PMC7723592/ /pubmed/33313150 http://dx.doi.org/10.21037/atm-20-3200 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Li, Xuanlin Yu, Xueqing Xie, Yang Feng, Zhenzhen Ma, Yanfang Chen, Yaolong Li, Jiansheng Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title_full | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title_fullStr | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title_full_unstemmed | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title_short | Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
title_sort | critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723592/ https://www.ncbi.nlm.nih.gov/pubmed/33313150 http://dx.doi.org/10.21037/atm-20-3200 |
work_keys_str_mv | AT lixuanlin criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT yuxueqing criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT xieyang criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT fengzhenzhen criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT mayanfang criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT chenyaolong criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis AT lijiansheng criticalappraisalofthequalityofclinicalpracticeguidelinesforidiopathicpulmonaryfibrosis |